Charleston, SC -- (SBWIRE) -- 10/04/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: OriginOil Inc (OTCMKTS:OOIL), Green Endeavors Inc (OTCMKTS:GRNE), Arch Therapeutics Inc (OTCBB:ARTH), Cellceutix Corp (OTCMKTS:CTIX)
OriginOil Inc (OTCMKTS:OOIL) increased +23.33% and closed at $0.352 on a traded volume of 643,916 shares, in comparison to 179,238 shares of average trading volume. So far this year, the stock is down over -56.06%.
The company has a total market capitalization of $14.84 million and its total outstanding shares are 42.21 million. OriginOil, Inc. develops water cleanup technology for the oil and gas, algae, and other water-intensive industries. Its patent-pending Electro Water Separation (EWS) process removes organic material from large quantities of water without the need for chemicals.
What was the Moving Force behind OOIL On Bullish Run? Read This Research Report
Green Endeavors Inc (OTCMKTS:GRNE) plunged -31.48% and closed at $0.0037 on a traded volume of 28.63 million shares, whereas its average trading volume is 1.17 million shares. In the last three months, the stock is down -38.33%. The Intra-day range for the stock is $0.0026 and $0.0068.
Green Endeavors, Inc. owns and operates hair care salons in Utah. The company operates two Aveda Lifestyle Salons in Liberty Heights and Marmalade districts of Salt Lake City, Utah.
Will GRNE Get Buyers Even After The Recent Rally? Find Out Here
Arch Therapeutics Inc (OTCBB:ARTH) jumped up +1.61% and closed at $0.285. So far in three months, the stock is down -67.30%. The 52-week range for the stock is $0.01 and $1.36 and during the previous trading session the stock touched its highest price at $0.30. Its introductory price for the day was $0.30, with the overall traded volume of 315,818 shares.
Arch Therapeutics, Inc. operates as a life science company developing liquid polymers containing tiny peptides intended to form gel-like barriers over surgical wounds to stop or control bleeding.
For How Long ARTH will Fight for Profitability? Read This Trend Analysis report
Cellceutix Corp (OTCMKTS:CTIX), after opening its shares at the price of $1.81, dropped -3.28% to close at $1.77 for the day. The stock moved on a traded volume of 161,154 shares, in comparison to 318,209 shares of average trading volume.
The 52-week range for the stock is $0.77 and $2.47 and during the previous trading session the stock touched its highest price at $1.84. Its introductory price for the day was $1.81. Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease.
Has CTIX Found The Bottom And Ready To Gain Momentum? Find Out Here
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)